Carcinoma, Transitional Cell: all 725 studies
Page 2 of 8. Open to participants first (201), then studies with results posted, then the rest; newest registration first within each.
- A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial CarcinomaRecruitingNCT06639347Phase 1/2
- A Phase 2 Clinical Study of ABSK061 and ABSK043RecruitingNCT06632262Phase 2
- Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUCRecruitingNCT06598761
- 9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial CancerRecruitingNCT06592326Phase 3
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruitingNCT06582017Phase 1
- The Efficacy of the IUrisure for Detection of Recurrent Urothelial CarcinomaRecruitingNCT06564363
- A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial CancerRecruitingNCT06524544Phase 3
- Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene AlterationsRecruitingNCT06511648Phase 2
- Neoadjuvant Radiotherapy for High-risk UTUCNot yet recruitingNCT06472752
- Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With HematuriaNot yet recruitingNCT06469229
- This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsRecruitingNCT06451497Phase 1
- An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGAvailableNCT06443944
- Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior ImmunotherapyRecruitingNCT06439836Phase 1
- A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial CarcinomaRecruitingNCT06405425Phase 2
- Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)RecruitingNCT06396533
- Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.RecruitingNCT06394869Not applicable
- A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.Not yet recruitingNCT06364904Phase 3
- Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial CancerRecruitingNCT06356155Phase 2
- DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUCRecruitingNCT06354231Phase 2
- Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLCRecruitingNCT06332755Phase 1
- A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)RecruitingNCT06330064Phase 1/2
- Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial CancerRecruitingNCT06310759
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsRecruitingNCT06293898Phase 1
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 1
- Stress-reducing Intervention in Urothelial CarcinomaRecruitingNCT06269536Not applicable
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramRecruitingNCT06265285Phase 2
- Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell CarcinomaRecruitingNCT06262516Not applicable
- Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial CarcinomaRecruitingNCT06257017Phase 2
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial CarcinomaRecruitingNCT06235268
- Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)RecruitingNCT06218433Not applicable
- Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing TherapyRecruitingNCT06204406
- A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial CancerRecruitingNCT06196736Phase 3
- Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical CystectomyRecruitingNCT06184516Phase 2
- A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial CarcinomaRecruitingNCT06178601Phase 2
- Study on the Quality of Life and Pathological State in Patients Who Underwent Radical CystectomyRecruitingNCT06170177
- Translational Cancer Observational ProtocolRecruitingNCT06169436
- Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.RecruitingNCT06167356
- Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...RecruitingNCT06161532Phase 2
- Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric AssessmentsRecruitingNCT06138561
- 18F-LN1 PET/CT in Urothelial CarcinomasRecruitingNCT06120413
- Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral CancerRecruitingNCT06120387
- Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUCRecruitingNCT06120374
- Liquid Biospy for Urinary CancersRecruitingNCT06116396
- Immunotherapy in Upper Tract Urothelial CarcinomaNot yet recruitingNCT06113367
- Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)RecruitingNCT06101290Not applicable
- 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial CancerRecruitingNCT06079112Phase 1/2
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
- A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving TrialRecruitingNCT06040762Not applicable
- Safely Reduce Cystoscopic Evaluations for Hematuria PatientsRecruitingNCT06026189Not applicable
- 18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.Not yet recruitingNCT05983796Not applicable
- Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial CarcinomaNot yet recruitingNCT05979909Phase 1
- A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid TumorsRecruitingNCT05965856Phase 2
- A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial CarcinomaRecruitingNCT05917158Phase 2
- Utidelone Treated for the Recurrent or Metastatic Urothelial CarcinomaRecruitingNCT05895864Phase 2
- UroCAD for Hematuria Evaluation--A Prospective, Multi-center StudyNot yet recruitingNCT05893316
- uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With JelmytoRecruitingNCT05874921
- Single-Dose Intravesical Chemotherapy After Diagnostic URSNot yet recruitingNCT05810623Phase 3
- A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUCRecruitingNCT05775874Phase 2
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsRecruitingNCT05733000Phase 2
- Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial CarcinomaRecruitingNCT05723991Phase 4
- A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid TumorsRecruitingNCT05706129Phase 1/2
- Bladder Cancer Screening TrialRecruitingNCT05646485Not applicable
- Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial CancerRecruitingNCT05600127Phase 2
- A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)RecruitingNCT05562830Phase 1/2
- A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin CancerRecruitingNCT05562791Phase 1
- Named Patient Program for Mitomycin for Pyelocalyceal SolutionAvailableNCT05494411
- A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial CarcinomaNot yet recruitingNCT05488353Phase 4
- A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in ChinaRecruitingNCT05337189
- Intravesical BCG: is the Urinary Bladder Ready to Receive itNot yet recruitingNCT05335512
- Nectin-4 Specific LMW PET Probe Imaging in Urothelial CarcinomaRecruitingNCT05321316Not applicable
- A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial CarcinomaRecruitingNCT05302284Phase 3
- ARON-2 Study-Multicentric International Retrospective StudyRecruitingNCT05290038
- Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial CarcinomaRecruitingNCT05276167Not applicable
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsRecruitingNCT05269381Phase 1/2
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsRecruitingNCT05176483Phase 1
- A Study of NX-1607 in Adults With Advanced MalignanciesRecruitingNCT05107674Phase 1
- Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGSRecruitingNCT04994197
- GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid TumorsRecruitingNCT04977453Phase 1/2
- Bio Clinical Collection of Urothelial CarcinomaRecruitingNCT04970472
- Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma DetectionRecruitingNCT04948528
- A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsRecruitingNCT04895709Phase 1/2
- Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and RadiotherapyRecruitingNCT04892849
- A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2RecruitingNCT04879329Phase 2
- Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial CancerRecruitingNCT04878029Phase 1
- Sacituzumab Govitecan Plus EV in Metastatic UCRecruitingNCT04724018Phase 1/2
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME TrialRecruitingNCT04693377Not applicable
- TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial CarcinomaRecruitingNCT04678362Phase 2
- Urine Omics Predicting IO Therapy Responses in mUC PatientsRecruitingNCT04641936
- An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or BiopsyRecruitingNCT04623502Not applicable
- Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary TractRecruitingNCT04617756Phase 2
- Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial CarcinomaRecruitingNCT04588168Not applicable
- A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial CarcinomaRecruitingNCT04486781Phase 2
- Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial CarcinomaNot yet recruitingNCT04339933
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)RecruitingNCT04198766Phase 1/2
- Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") PatientsRecruitingNCT03945162Phase 2
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsRecruitingNCT03866382Phase 2
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Registry Platform Urologic CancerRecruitingNCT03374267
- Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without NephroureterectomyNot yet recruitingNCT03345134Phase 2